Cargando…
Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126611/ https://www.ncbi.nlm.nih.gov/pubmed/35618094 http://dx.doi.org/10.1016/j.kint.2022.05.008 |
| _version_ | 1784712163701555200 |
|---|---|
| author | Benotmane, Ilies Velay, Aurélie Gautier-Vargas, Gabriela Olagne, Jérôme Thaunat, Olivier Fafi-Kremer, Samira Caillard, Sophie |
| author_facet | Benotmane, Ilies Velay, Aurélie Gautier-Vargas, Gabriela Olagne, Jérôme Thaunat, Olivier Fafi-Kremer, Samira Caillard, Sophie |
| author_sort | Benotmane, Ilies |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9126611 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | International Society of Nephrology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91266112022-05-24 Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant Benotmane, Ilies Velay, Aurélie Gautier-Vargas, Gabriela Olagne, Jérôme Thaunat, Olivier Fafi-Kremer, Samira Caillard, Sophie Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2022-08 2022-05-24 /pmc/articles/PMC9126611/ /pubmed/35618094 http://dx.doi.org/10.1016/j.kint.2022.05.008 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Benotmane, Ilies Velay, Aurélie Gautier-Vargas, Gabriela Olagne, Jérôme Thaunat, Olivier Fafi-Kremer, Samira Caillard, Sophie Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant |
| title | Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant |
| title_full | Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant |
| title_fullStr | Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant |
| title_full_unstemmed | Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant |
| title_short | Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant |
| title_sort | pre-exposure prophylaxis with 300 mg evusheld elicits limited neutralizing activity against the omicron variant |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126611/ https://www.ncbi.nlm.nih.gov/pubmed/35618094 http://dx.doi.org/10.1016/j.kint.2022.05.008 |
| work_keys_str_mv | AT benotmaneilies preexposureprophylaxiswith300mgevusheldelicitslimitedneutralizingactivityagainsttheomicronvariant AT velayaurelie preexposureprophylaxiswith300mgevusheldelicitslimitedneutralizingactivityagainsttheomicronvariant AT gautiervargasgabriela preexposureprophylaxiswith300mgevusheldelicitslimitedneutralizingactivityagainsttheomicronvariant AT olagnejerome preexposureprophylaxiswith300mgevusheldelicitslimitedneutralizingactivityagainsttheomicronvariant AT thaunatolivier preexposureprophylaxiswith300mgevusheldelicitslimitedneutralizingactivityagainsttheomicronvariant AT fafikremersamira preexposureprophylaxiswith300mgevusheldelicitslimitedneutralizingactivityagainsttheomicronvariant AT caillardsophie preexposureprophylaxiswith300mgevusheldelicitslimitedneutralizingactivityagainsttheomicronvariant |